200556 Mobile healthcare interventions for Top-25 public health diseases: A systematic review

Monday, November 9, 2009

Ajay Bakshi, MCh , Health Systems Institute, McKinsey and Company, Dubai, United Arab Emirates
Emma Hannay, MBChB, MPH , McKinsey & Company, Dubai, United Arab Emirates
Context: Mobile phones are now ubiquitous. More than 4 billion people have mobile devices, and mobile networks cover more than 95% of human population. However, health systems still struggle to deliver basic healthcare services to large segments of populations. Some of these services could easily be delivered using mobile technologies that include voice, text messages, data transfer, still images, short videos and software applications residing on cell phones.

Methods: We undertook a detailed study of top-25 diseases that cause the most public health burden and evaluated the evidence that supports the currently established interventions. Next, we reviewed the literature to identify any mobile healthcare interventions that have been proposed for the selected diseases. We then developed a framework and conducted structured problem solving to identify new mobile interventions that could help improve outcomes for each of the selected diseases. This brainstorming included matching every potential mobile technology with each disease condition to generate new options. Finally, we interviewed leading disease and technology experts to validate the interventions database.

Results: We have generated a database of 100+ mobile healthcare interventions that could be deployed against leading disease conditions. We estimate that successful implementation of these interventions could have a huge impact on global burden of diseases. However, the clinical efficacy and cost effectiveness of each of these interventions needs to be demonstrated in rigorous studies. We invite public health investigators for setting up collaborative studies to evaluate the proposed novel mobile healthcare interventions.

Learning Objectives:
1. Review the list of mobile healthcare interventions for leading public health diseases 2. Discuss the design of studies needed for demonstrating the efficacy of these interventions

Keywords: International Health, Telehealth

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a neurosurgeon with clinical experience of 5+ years post residency. Have been on the research faculty of Drexel University School of Medicine, Philadelphia, where I developed new therapies for spinal cord injury. Have published more than 15 peer reviewed articles in leading journals including Journal of Neurosurgery, Journal of Neurotrauma. Have also been a reviewer of grants and journal articles. Now I lead the Mobile healthcare group at the Health Systems Institute of McKinsey and Company, a consulting firm.
Any relevant financial relationships? Yes

Name of Organization Clinical/Research Area Type of relationship
McKinsey and Company Health Systems Employment (includes retainer)

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.